AbClon Inc. (AbClon) aksje
174900.KQ
Stengt₩33,500.00-600.00 (-1.76%)
Laster graf...
AbClon
Market Cap
$639,613,730,816
Åpning35,200.00
Høy35,450.00
Lav33,000.00
Volum192.89k
P/EN/A
Markedsverdi639.61B
52-ukers høy95,800.00
52-ukers lav9,770.00
Gj.sn. volum435.74k
UtbytteN/A
Beta0.71
EPSN/A
Om AbClon Inc. (AbClon) aksje
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.
Selskapsinformasjon
Børs: KOSDAQ (KOE)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
1401 285, Digital-ro
08381 Seoul, South Korea
08381 Seoul, South Korea
Telefon: + 82 2 2109 1294
Nettside: https://www.abclon.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål